LA VILLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.322
EU - Europa 3.843
AS - Asia 2.674
SA - Sud America 300
AF - Africa 78
OC - Oceania 60
Totale 14.277
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.251
RU - Federazione Russa 1.517
SG - Singapore 742
HK - Hong Kong 527
CN - Cina 515
SE - Svezia 475
IE - Irlanda 404
VN - Vietnam 282
PL - Polonia 279
KR - Corea 275
UA - Ucraina 260
BR - Brasile 248
IT - Italia 226
DE - Germania 221
FI - Finlandia 139
FR - Francia 129
IN - India 101
GB - Regno Unito 90
AU - Australia 60
JP - Giappone 57
CH - Svizzera 49
TR - Turchia 44
CA - Canada 34
BD - Bangladesh 32
JO - Giordania 27
AR - Argentina 23
CI - Costa d'Avorio 21
NG - Nigeria 18
NL - Olanda 18
MX - Messico 16
IQ - Iraq 15
CO - Colombia 11
ZA - Sudafrica 10
PK - Pakistan 9
BE - Belgio 7
EG - Egitto 7
VE - Venezuela 7
EC - Ecuador 6
ID - Indonesia 6
SC - Seychelles 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
HN - Honduras 5
MA - Marocco 5
UZ - Uzbekistan 5
CL - Cile 4
CR - Costa Rica 4
ES - Italia 4
PH - Filippine 4
PT - Portogallo 4
SA - Arabia Saudita 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
GT - Guatemala 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
IL - Israele 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
UG - Uganda 1
Totale 14.277
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.510
Fairfield 624
Ashburn 578
Singapore 507
Chandler 427
Hong Kong 427
Jacksonville 415
Dublin 404
San Jose 329
Woodbridge 322
Cambridge 283
Warsaw 277
Seattle 273
Seoul 270
Houston 237
Wilmington 237
Beijing 183
Los Angeles 128
Buffalo 120
The Dalles 120
Princeton 102
Ann Arbor 93
Ho Chi Minh City 90
Hanoi 84
Lauterbourg 83
Boardman 82
Boston 79
Dallas 69
Melbourne 60
Lawrence 56
Mumbai 56
Tokyo 56
Bern 49
Hefei 49
Altamura 46
Medford 43
San Diego 41
Munich 37
Moscow 35
New York 31
Izmir 28
Paris 24
Turku 23
Milan 22
Shanghai 22
Abidjan 21
Kent 20
Norwalk 20
São Paulo 19
Abuja 18
Florence 18
Council Bluffs 14
Helsinki 14
Auburn Hills 13
Falls Church 13
London 13
Redondo Beach 13
Bremen 12
Da Nang 11
Dearborn 11
Frankfurt am Main 11
Frankfurt Am Main 10
Haiphong 10
Orem 10
Toronto 10
Verona 10
Baghdad 9
Biên Hòa 9
Chennai 9
Andover 8
Atlanta 8
Tianjin 8
Yubileyny 8
Brooklyn 7
Chicago 7
Guangzhou 7
Rio de Janeiro 7
Salerno 7
Amman 6
Brussels 6
Curitiba 6
Hillsboro 6
Manchester 6
Montreal 6
San Francisco 6
Stockholm 6
Washington 6
Amsterdam 5
Belo Horizonte 5
Brasília 5
Charlotte 5
Johannesburg 5
Karachi 5
Mexico City 5
Ninh Bình 5
Poplar 5
Bogotá 4
Cairo 4
Dong Ket 4
Pune 4
Totale 9.531
Salva come PNG Salva come JPEG
Nome #
THAD in biliary duct disease 342
Spiral computed tomography versus ultrasound in the follow up of cirrhotic patients previously treated for hepatocellular carcinoma: a prospective study 305
The kinin system and other vasoactive substances in chronic liver disease. 236
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 219
"Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease 213
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 211
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 199
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 194
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 193
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 189
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 185
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 184
Analysis of HCV persistence in patients with sustained virological response 184
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 181
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 179
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 178
Ascites and hepatorenal syndrome 177
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 177
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 174
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 174
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 173
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 173
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 172
Functional renal alterations in chronic liver diseases. 170
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 170
Liver-kidney pathophysiological interrelationships in liver diseases. 168
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 168
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 163
T(14;18) translocation in chronic hepatitis C virus infection 162
Loop diuretic therapy in liver cirrhosis with ascites 162
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 161
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 158
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 157
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 156
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 154
CARDIOVASCULAR EFFECTS OF PARATHYROID HORMONE: A STUDY IN HEALTHY SUBJECTS AND NORMOTENSIVE PATIENTS WITH MILD PRIMARY HYPERPARATHYROIDISM 152
Pathogenesis and treatment of ascites in hepatic cirrhosis. 151
In vivo evidence that endogenous dopamine modulates sympathetic activity in man. 151
Torasemide in the treatment of patients with cirrhosis and ascites. 149
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 149
Hepato-systemic gradient of carbon monoxide in cirrhosis. 149
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. 146
Hemodynamic alterations in liver cirrhosis. 146
Transient Hepatic Attenuation Differences - Pictorial Essay 143
High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure 143
[Determination of prostaglandin E2 and F2 alpha in the urine of cirrhotic patients: comparison of 3 different chromatographic methods] 142
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 141
Uveitis in autoimmune hepatitis: a case report. 139
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 138
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 138
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 138
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 134
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications] 132
Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure. 130
Comportamento dell'infezione da HCV in pazienti trapiantati per HCC complicante una cirrosi HCV-correlata 130
Pathogenesis and treatment of ascites in hepatic cirrhosis. 129
Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans. 129
Il Fegato: Fisiopatologia, Clinica, Terapia 128
Renal impairement in chronic liver diseases with and without cholestasis 127
Pathogenesis and management of the hepatorenal syndrome. 127
Renal effects of atrial natriuretic peptide during dopa-decarboxylase inhibition in patients with essential hypertension. 126
Vascular reserve in the lower limbs of cirrhotic patients: a duplex Doppler ultrasound study. 125
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. 125
Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. 121
Hemodynamic, renal and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 120
Cerebral autoregulation in patients with cirrhosis and ascites. A transcranial Doppler study. 119
Systemic haemodynamics, renal and platelet function during chronic propranolol ADMINISTRATION IN PATIENTS WITH COMPENSATED CIRRHOSIS 119
Multiple immune disorders in unrecognized celiac disease: a case report 118
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. 118
Hepatorenal syndrome and its treatment today. 118
Effects of clonidine on power spectral analysis of heart rate variability in mild essential hypertension. 116
Arachidonic acid derivatives and renal function in liver cirrhosis. 116
Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. 116
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour 115
Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites 114
Dopamine and sympathoadrenal activity in man. 114
Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension. 113
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 112
Long course and prognostic factors of virus-induced cirrhosis of the liver. 107
Effects of acute clonidine administration on power spectral analysis of heart rate variability in healthy humans. 104
Effects of OKY 046, a thromboxane-sinthase inhibitor, on renal function in non-azotemic cirrhotic patients with ascites 104
Hepatitis C virus infction of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. 101
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion. 100
Refractory ascites: definition, pathogenesis and treatment. 99
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion. 94
Low-dose C-natriuretic peptide does not affect cardiac and renal function in man 94
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 91
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 89
Persistence of HCV in hepatic and extrahepatic cells from asymptomatic non viremic chronic anti-HCV carriers. 89
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 88
Virological analysis of the healthy HCV carrier state: prognostic factors and HCV persistence in non viraemic subjects 87
Renal Impairment In Chronic Liver-Diseases With And Without Cholestasis. 86
La Cirrosi Epatica Virus-correlata: Storia Naturale, patogenesi e implicazioni cliniche dellew complicanze. 86
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 85
Hemodynamic derangement and cardiac dysfunction in cirrhosis. 85
Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. 84
Il fegato: fisiopatologia, clinica, terapia 84
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 82
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma 79
pathogenetic factors of renal dysfuntion in chronic liver disease 77
Totale 14.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.586
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 0 0 0 0 0 0 0 68 84
2021/2022636 11 77 20 21 20 32 21 35 31 23 162 183
2022/20231.746 163 191 93 126 177 321 241 113 186 14 58 63
2023/2024495 25 76 102 28 36 69 14 112 6 4 12 11
2024/20254.154 125 431 288 636 1.453 389 30 247 231 89 119 116
2025/20263.505 555 548 251 326 430 126 445 186 362 202 74 0
Totale 14.288